Adhikari, A.N., Gallagher, R.C., Wang, Y., Currier, R.J., Amatuni, G., Bassaganyas, L., Chen, F., Kundu, K., Kvale, M., Mooney, S.D., et al., 2020. The role of exome sequencing in newborn screening for inborn errors of metabolism. Nat. Med. 26, 1392-1397.
|
Almannai, M., Marom, R.,Sutton, V.R., 2016. Newborn screening:a review of history, recent advancements, and future perspectives in the era of next generation sequencing. Curr. Opin. Pediatr. 28, 694-699.
|
Bailey, D.B., Jr.,Gehtland, L., 2015. Newborn screening:evolving challenges in an era of rapid discovery. JAMA 313, 1511-1512.
|
Bassaganyas, L., Freedman, G., Vaka, D., Wan, E., Lao, R., Chen, F., Kvale, M., Currier, R.J., Puck, J.M.,Kwok, P.Y., 2018. Whole exome and whole genome sequencing with dried blood spot DNA without whole genome amplification. Hum. Mutat. 39, 167-171.
|
Beckmann, J.S., 2015. Can we afford to sequence every newborn baby's genome? Hum. Mutat. 36, 283-286.
|
Bell, C.J., Dinwiddie, D.L., Miller, N.A., Hateley, S.L., Ganusova, E.E., Mudge, J., Langley, R.J., Zhang, L., Lee, C.C., Schilkey, F.D., et al., 2011. Carrier testing for severe childhood recessive diseases by next-generation sequencing. Sci. Transl. Med. 3, 65ra4.
|
Berg, J.S., Agrawal, P.B., Bailey, D.B., Jr., Beggs, A.H., Brenner, S.E., Brower, A.M., Cakici, J.A., Ceyhan-Birsoy, O., Chan, K., Chen, F., et al., 2017. Newborn Sequencing in Genomic Medicine and Public Health. Pediatrics 139, e20162252.
|
Bombard, Y., Miller, F.A., Hayeems, R.Z., Avard, D., Knoppers, B.M., Cornel, M.C.,Borry, P., 2009. The expansion of newborn screening:is reproductive benefit an appropriate pursuit? Nat. Rev. Genet. 10, 666-667.
|
Cdc, 2001. Using tandem mass spectrometry for metabolic disease screening among newborns. A report of a work group. MMWR Recomm. Rep. 50, 1-34.
|
Ceyhan-Birsoy, O., Murry, J.B., Machini, K., Lebo, M.S., Yu, T.W., Fayer, S., Genetti, C.A., Schwartz, T.S., Agrawal, P.B., Parad, R.B., et al., 2019. Interpretation of Genomic Sequencing Results in Healthy and Ill Newborns:Results from the BabySeq Project. Am. J. Hum. Genet. 104, 76-93.
|
Chace, D.H., Kalas, T.A.,Naylor, E.W., 2002. The application of tandem mass spectrometry to neonatal screening for inherited disorders of intermediary metabolism. Annu. Rev. Genomics Hum. Genet. 3, 17-45.
|
Chen, R.G., Qian, D.L.,Guo, D., 1986. Benefit of neonatal screening for phenylketouria. A report of the first case treated in China. Chin. Med. J. (Engl.) 99, 513-514.
|
Chen, R.G., Sun, M., Ni, Y.Y., Pan, X.S., Chen, J.Z., Zhang, Y.F., Liu, H., Zhang, M.H., Xu, H.Z., Wu, Y.L., et al., 1984. Neonatal hypothyroidism, phenylketonuria and galactosemia screening in metropolitan Shanghai. Chin. Med. J. (Engl.) 97, 61-65.
|
Dai, P., Huang, L.H., Wang, G.J., Gao, X., Qu, C.Y., Chen, X.W., Ma, F.R., Zhang, J., Xing, W.L., Xi, S.Y., et al., 2019. Concurrent Hearing and Genetic Screening of 180,469 Neonates with Follow-up in Beijing, China. Am. J. Hum. Genet. 105, 803-812.
|
Frankel, L.A., Pereira, S.,McGuire, A.L., 2016. Potential Psychosocial Risks of Sequencing Newborns. Pediatrics 137 Suppl 1, S24-29.
|
Friedman, J.M., Cornel, M.C., Goldenberg, A.J., Lister, K.J., Senecal, K., Vears, D.F., Global Alliance for, G., Health, R., Ethics Working Group Paediatric Task, T., 2017. Genomic newborn screening:public health policy considerations and recommendations. BMC Med. Genomics 10, 9.
|
Fu, C., Luo, S., Li, Q., Xie, B., Yang, Q., Geng, G., Lin, C., Su, J., Zhang, Y., Wang, J., et al., 2018. Newborn screening of glucose-6-phosphate dehydrogenase deficiency in Guangxi, China:determination of optimal cutoff value to identify heterozygous female neonates. Sc.i Rep. 8, 833.
|
Gelb, M.H., 2018. Newborn Screening for Lysosomal Storage Diseases:Methodologies, Screen Positive Rates, Normalization of Datasets, Second-Tier Tests, and Post-Analysis Tools. Int. J. Neonatal Screen 4, 23.
|
Goldenberg, A.J.,Sharp, R.R., 2012. The ethical hazards and programmatic challenges of genomic newborn screening. JAMA 307, 461-462.
|
Guthrie, R., 1969. Screening for phenylketonuria. Triangle 9, 104-109.
|
Guthrie, R.,Susi, A., 1963. A Simple Phenylalanine Method for Detecting Phenylketonuria In Large Populations Of Newborn Infants. Pediatrics 32, 338-343.
|
Hu, X., Li, N., Xu, Y., Li, G., Yu, T., Yao, R.E., Fu, L., Wang, J., Yin, L., Yin, Y., et al., 2018. Proband-only medical exome sequencing as a cost-effective first-tier genetic diagnostic test for patients without prior molecular tests and clinical diagnosis in a developing country:the China experience. Genet. Med. 20, 1045-1053.
|
Kennedy, C.,McCann, D., 2004. Universal neonatal hearing screening moving from evidence to practice. Arch. Dis. Child Fetal Neonatal Ed. 89, F378-383.
|
Kingsmore, S.F., 2016. Newborn testing and screening by whole-genome sequencing. Genet. Med. 18, 214-216.
|
Lai, K., Huang, G., Su, L.,He, Y., 2017. The prevalence of thalassemia in mainland China:evidence from epidemiological surveys. Sci. Rep. 7, 920.
|
Landau, Y.E., Lichter-Konecki, U.,Levy, H.L., 2014. Genomics in newborn screening. J. Pediatr. 164, 14-19.
|
Lee, H., Lim, J., Shin, J.E., Eun, H.S., Park, M.S., Park, K.I., Namgung, R.,Lee, J.S., 2019. Implementation of a targeted next-generation sequencing panel for constitutional newborn screening in high-risk neonates. Yonsei Med. J. 60, 1061-1066.
|
Liu, S.R.,Zuo, Q.H., 1986. Newborn screening for phenylketonuria in eleven districts. Chin. Med. J. (Engl.) 99, 113-118.
|
Luo, X., Wang, R., Fan, Y., Gu, X.,Yu, Y., 2018. Next-generation sequencing as a second-tier diagnostic test for newborn screening. J. Pediatr. Endocrinol. Metab. 31, 927-931.
|
Mak, C.M., Lee, H.C., Chan, A.Y.,Lam, C.W., 2013. Inborn errors of metabolism and expanded newborn screening:review and update. Crit. Rev. Clin. Lab. Sci. 50, 142-162.
|
Pereira, S., Robinson, J.O., Gutierrez, A.M., Petersen, D.K., Hsu, R.L., Lee, C.H., Schwartz, T.S., Holm, I.A., Beggs, A.H., Green, R.C., et al., 2019. Perceived Benefits, Risks, and Utility of Newborn Genomic Sequencing in the BabySeq Project. Pediatrics 143, S6-S13.
|
Posey, J.E., Rosenfeld, J.A., James, R.A., Bainbridge, M., Niu, Z., Wang, X., Dhar, S., Wiszniewski, W., Akdemir, Z.H., Gambin, T., et al., 2016. Molecular diagnostic experience of whole-exome sequencing in adult patients. Genet. Med. 18, 678-685.
|
Qi, Y., Ma, Y.N.,Pan, H., 2017.[Personal evaluation on gene test to prevent birth defects]. Zhonghua Yi Xue Za Zhi 97, 1207-1208.
|
Rashed, M.S., 2001. Clinical applications of tandem mass spectrometry:ten years of diagnosis and screening for inherited metabolic diseases. J. Chromatogr B Biomed. Sci. Appl. 758, 27-48.
|
Reinstein, E., 2015. Challenges of using next generation sequencing in newborn screening. Genet. Res. (Camb.) 97, e21.
|
Retterer, K., Juusola, J., Cho, M.T., Vitazka, P., Millan, F., Gibellini, F., Vertino-Bell, A., Smaoui, N., Neidich, J., Monaghan, K.G., et al., 2016. Clinical application of whole-exome sequencing across clinical indications. Genet. Med. 18, 696-704.
|
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W.W., Hegde, M., Lyon, E., Spector, E., et al., 2015. Standards and guidelines for the interpretation of sequence variants:a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 17, 405-424.
|
Roberts, J.S., Dolinoy, D.,Tarini, B., 2014. Emerging issues in public health genomics. Annu Rev Genomics Hum. Genet. 15, 461-480.
|
Shang, X., Peng, Z., Ye, Y., Asan, Zhang, X., Chen, Y., Zhu, B., Cai, W., Chen, S., Cai, R., et al., 2017. Rapid targeted next-generation sequencing platform for molecular screening and clinical genotyping in subjects with hemoglobinopathies. EBioMedicine 23, 150-159.
|
Tarini, B.A., Christakis, D.A., Welch, H.G., 2006. State newborn screening in the tandem mass spectrometry era:more tests, more false-positive results. Pediatrics 118, 448-456.
|
Tarini, B.A., Goldenberg, A.J., 2012. Ethical issues with newborn screening in the genomics era. Annu. Rev. Genomics Hum. Genet. 13, 381-393.
|
VanNoy, G.E., Genetti, C.A., McGuire, A.L., Green, R.C., Beggs, A.H., Holm, I.A.,BabySeq Project, G., 2019. Challenging the current recommendations for carrier testing in children. Pediatrics 143, S27-S32.
|
Wilcken, B., Wiley, V., Hammond, J.,Carpenter, K., 2003. Screening newborns for inborn errors of metabolism by tandem mass spectrometry. N. Engl. J. Med. 348, 2304-2312.
|
Wilson, J.M.,Jungner, Y.G., 1968.[Principles and practice of mass screening for disease]. Bol. Oficina Sanit Panam. 65, 281-393.
|
Xiong, F., Sun, M., Zhang, X., Cai, R., Zhou, Y., Lou, J., Zeng, L., Sun, Q., Xiao, Q., Shang, X., et al., 2010. Molecular epidemiological survey of haemoglobinopathies in the Guangxi Zhuang Autonomous Region of southern China. Clin. Genet. 78, 139-148.
|
Yan, T., Cai, R., Mo, O., Zhu, D., Ouyang, H., Huang, L., Zhao, M., Huang, F., Li, L., Liang, X., et al., 2006. Incidence and complete molecular characterization of glucose-6-phosphate dehydrogenase deficiency in the Guangxi Zhuang autonomous region of southern China:description of four novel mutations. Haematologica 91, 1321-1328.
|
Yang, Y., Muzny, D.M., Reid, J.G., Bainbridge, M.N., Willis, A., Ward, P.A., Braxton, A., Beuten, J., Xia, F., Niu, Z., et al., 2013. Clinical whole-exome sequencing for the diagnosis of mendelian disorders. N. Engl. J. Med. 369, 1502-1511.
|